From
Books Puddle, Woodside, NY, U.S.A.
Seller rating 4 out of 5 stars
AbeBooks Seller since November 22, 2018
pp. 208. Seller Inventory # 2651427933
The Path from Biomarker Discovery to Regulatory Qualification is a unique guide that focuses on biomarker qualification, its history and current regulatory settings in both the US and abroad. This multi-contributed book provides a detailed look at the next step to developing biomarkers for clinical use and covers overall concepts, challenges, strategies and solutions based on the experiences of regulatory authorities and scientists. Members of the regulatory, pharmaceutical and biomarker development communities will benefit the most from using this book―it is a complete and practical guide to biomarker qualification, providing valuable insight to an ever-evolving and important area of regulatory science.
For complimentary access to chapter 13, 'Classic' Biomarkers of Liver Injury, by John R. Senior, Associate Director for Science, Food and Drug Administration, Silver Spring, Maryland, USA, please visit the following site: http://tinyurl.com/ClassicBiomarkers
About the Authors:
PhD, Vice President, Strategic Regulatory Intelligence, Vertex Pharmaceuticals, Cambridge, MA
William B. Mattes, PhD, DABT, Senior Director of COPD Biomarkers Qualification Consortium, COPD Foundation and Founder and Principal, PharmPoint Consulting
Title: The Path from Biomarker Discovery to ...
Publisher: Elsevier
Publication Date: 2013
Binding: Soft cover
Condition: New